By Lisa Maria Garza and Jim Forsyth DALLAS (Reuters) – U.S. President Barack Obama signed a disaster declaration late on Friday for areas in Texas hammered by severe weather that killed at least 21 people, caused massive flooding and prompted evacuations this week. Storms that battered North Texas on Thursday and Friday added more runoff to swollen rivers and prompted hundreds of calls for help in Dallas, where some areas
By Phil Stewart WASHINGTON (Reuters) – The U.S. military said on Friday it discovered even more suspected shipments of live anthrax than previously thought, both in the United States and abroad, and ordered a sweeping review of practices meant to inactivate the bacteria. The Pentagon said a total of 11 states, two more than it first acknowledged, received “suspect samples,” as did Australia and South Korea. It had previously only
WASHINGTON (AP) — Blaming a “handful of senators” for stalled national security legislation, President Barack Obama said Friday he has told Senate Majority Leader Mitch McConnell and other senators that he expects them to take action swiftly to extend key Patriot Act provisions.
DALLAS (AP) — Authorities said Friday they reclaimed four more bodies from Texas waters, adding to the growing death toll inflicted by record-setting storms that continue to submerge highways and flood homes.
The election of a woman president would mean that for the first time, the first lady would be … a man.
Despite scandal all around him, Sepp Blatter remained FIFA’s president thanks to a voting bloc he’s spent years building using old-school politics.
Immunotherapy, which has shown remarkable success against advanced melanoma skin cancers, is now being used to target other cancers that are tough to treat. The results of several clinical trials were presented on the opening day of the American Society of Clinical Oncology’s (ASCO) annual conference in Chicago on Friday. In some cases, immunotherapy has been shown to completely eradicate cancer.
CHICAGO (AP) — Having a little extra tissue taken off during breast cancer surgery greatly lowers the risk that some cancer will be left behind and require a second operation, according to a new study that could change care for more than 100,000 women in the United States alone each year.
After a diagnosis of localized breast cancer, women are often prescribed tamoxifen for five years to help prevent a recurrence, but researchers said Saturday another drug, anastrazole, may work better. The federally funded phase III study involved more than 3,100 postmenopausal women with a kind of breast cancer known as ductal carcinoma in situ, which was treated by removing the cancerous lump followed by a radiation regimen. Some women were
By Deena Beasley CHICAGO (Reuters) – A Phase III trial of Pfizer Inc’s drug Ibrance showed that, in combination with hormone therapy, the drug more than doubled the duration of disease control for women with the most common type of breast cancer. At the time of an interim analysis, patients given Ibrance in combination with AstraZeneca Plc’s Faslodex (fulvestrant), a widely used treatment to block estrogen, lived an average of
